Digging Deep

A Bird in The Hand

February 10, 2026

End of Banks in Canada?

September 16, 2024

Defense Metals in the Media

February 16, 2024

Our 2024 Predictions, Part 2

January 11, 2024

Our 2024 Predictions, Part 1

January 02, 2023

Can Gold Hit $3,000 in 2024?

29 December, 2023

Will Bitcoin ETFs Kill Gold?

November 21, 2023

What's Next for Gold?

06 June, 2023

Platinum and Palladium

February 2022

Transition to Production

June 15, 2021

Silver Suppression?!

February 02, 2021

Gold: Year in Review 2020, and 2021 Outlook

January 04, 2021

Gold has big year in 2020 and outlook for this year robust. Learn about monetary expansion and gold future prices.Read More

AbraPlata: CMR's full analysis of an Argentina focussed gold and silver junior

May 2020

The gold futures price reached US$1,767/ounce this week before retreating, which was the second time it has surpassed US$1,760 in the past two months, marking some of gold's highest levels in several years.Read More

$AMS - American Shared Hospital Services (AMS) Q4 2022 Earnings Call Transcript.

March 24, 2023 / seekingalpha.com

American Shared Hospital Services (NYSE:NYSE:AMS) Q4 2022 Earnings Conference Call March 24, 2023 1:00 PM ETCompany ParticipantsStephanie Prince - PCG AdvisoryRaymond Stachowiak - Executive...Read full newsRead More

$TWLO - Twilio: Now, The Focus Is On Profits.

March 24, 2023 / seekingalpha.com

Twilio is trading at a very cheap Read full newsRead More

$IDYA - Ideaya Biosciences Has A Strong Pipeline And Looks Investible.

March 24, 2023 / seekingalpha.com

IDEAYA Biosciences' platform is synthetic lethality targeting cancer. The company has produced solid proof of concept data. Click here for our review of IDYA.Read full newsRead More

$KOF - Coca-Cola FEMSA: More Upside Likely As Shares Hover Near Multi-Year Highs.

March 24, 2023 / seekingalpha.com

While many of the areas' stocks sport high valuations, Coca-Cola FEMSA has low earnings multiples and impressive growth potential. Read more about KOF here.Read full newsRead More

$GIS - General Mills: Recent Quarterly Results Highlight Some Important Areas Of Progress.

March 24, 2023 / seekingalpha.com

General Mills continues to perform exceptionally well relative to the broader equity market. Read more about GIS here.Read full newsRead More

$ONTTF - Oxford Nanopore: Attractive Long-Term Growth, Possible Buyout Scenario.

March 24, 2023 / seekingalpha.com

Oxford Nanopore Technologies plc creates the technology required for studying and analyzing molecules. Find out why I recommend a buy rating for ONTTF stock.Read full newsRead More

$PPH - PPH Fell As Much As The Market Despite Resilience.

March 24, 2023 / seekingalpha.com

We look at VanEck Pharmaceutical ETF when trying to get a read on the performance of the large-cap pharmaceutical industry. Read my analysis of PPH ETF.Read full newsRead More

$AAPL $BRK.A $BRK.B - Apple, Berkshire Hathaway, And No Finish Line.

March 24, 2023 / seekingalpha.com

In his Berkshire Hathaway letter, Warren Buffett wrote, "At Berkshire, there will be no finish line.Read full newsRead More

$IMPL - Impel Pharmaceuticals Inc. (IMPL) Q4 2022 Earnings Call Transcript.

March 24, 2023 / seekingalpha.com

Impel Pharmaceuticals Inc. (NASDAQ:NASDAQ:IMPL) Q4 2022 Earnings Conference Call March 24, 2023 8:30 AM ETCompany ParticipantsAdrian Adams - Chairman & Chief Executive OfficerLeonard...Read full newsRead More

$SQ - The Hindenburg Block Short Report Examined In Detail.

March 24, 2023 / seekingalpha.com

Yesterday, Hindenburg issued a long short report on Block and the stock dropped 15%. See how this could impact SQ stock's prospects.Read full newsRead More

$OSCR - Oscar Health Promises Focus On Margin Improvement.

March 24, 2023 / seekingalpha.com

Oscar Health reported Q4 2022 financial results on February 9, 2023. The firm provides health insurance to U.S. consumers. Read why I'm on Hold for OSCR stock.Read full newsRead More

RT @rbradthomas: Nice job with this @SeekingAlpha article @2MCAC:

March 24, 2023 / seekingalpha.com

Substantial valuation spreads emerged between REITs and rest of the market. Read why I see significant outperformance ahead for REITs as multiples normalize.Read full newsRead More

RT @MichaelMOTTCM: The Next Chapter Of The Bear Market Has Arrived

March 24, 2023 / seekingalpha.com

Fed is focused on inflation, and keeping rates high. The market is looking for the Fed to cut rates, as the yield curve steepens. Read more on the economy here.Read full newsRead More

$ALLY - Ally Financial: An Auto Bank Run Is Unlikely - Speculative Buy Here.

March 24, 2023 / seekingalpha.com

The recent moderation in Ally Financial's stock prices was unwarranted, given that it specialized in automotive loans & insurance. Click here to read my most recent analysis.Read full newsRead More

$BEKE - KE Results Show Green Shoots Of Recovery After Real Estate Winter.

March 24, 2023 / seekingalpha.com

KE Holdings recorded a modest but unexpected rise in the gross transaction value of existing homes in the last quarter.Read full newsRead More

$KOF - Coca-Cola FEMSA: Wait For A Better Entry.

March 24, 2023 / seekingalpha.com

Coca-Cola FEMSA, S.A.B. de C.V.'s stock price is currently priced much higher than its peers. Click here to read why I rate KOF stock a hold.Read full newsRead More

$XIACF $XIACY - Xiaomi Corporation (XIACF) Q4 2022 Earnings Call Transcript.

March 24, 2023 / seekingalpha.com

Xiaomi Corporation (OTCPK:XIACF) Q4 2022 Earnings Conference Call March 24, 2023 8:30 AM ETCompany ParticipantsAnita Chan - Head of IR and Corporate FinanceLu Weibing - Partner and...Read full newsRead More

$CCTG - CCSC Technology International Readies U.S. IPO Effort.

March 24, 2023 / seekingalpha.com

CCSC Technology International has filed proposed terms for a $12.5 million U.S. IPO. Learn why I'm on Hold for CCTG IPO.Read full newsRead More

$JPIN - JPIN: A Decent International Equity Fund With A Less Than Adequate Return.

March 24, 2023 / seekingalpha.com

JPMorgan Diversified Return International Equity ETF offers quarterly payouts and generated a 5-year annual average yields of 3.53%. Find out our JPIN review.Read full newsRead More

$APLS - Apellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy Market.

March 24, 2023 / seekingalpha.com

Apellis Pharmaceuticals received FDA approval for Syfovre (pegcetacoplan injection) for geographic atrophy secondary to age-related macular degeneration. Read more here.Read full newsRead More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok